Quntrol Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-07-2024
- Paid Up Capital ₹ 0.10 M
as on 26-07-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.59%
(FY 2023)
- Profit -13.29%
(FY 2023)
- Ebitda -14.79%
(FY 2023)
- Net Worth 42.03%
(FY 2023)
- Total Assets 22.18%
(FY 2023)
About Quntrol Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Riddhi Javeri and Sahil Javeri serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC294624
- Company No.
294624
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Quntrol Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Riddhi Javeri  | Director | 03-May-2017 | Current |
| Sahil Javeri | Director | 20-Sep-2019 | Current |
Financial Performance of Quntrol Laboratories.
Quntrol Laboratories Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.59% increase. The company also saw a substantial fall in profitability, with a 13.29% decrease in profit. The company's net worth Soared by an impressive increase of 42.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quntrol Laboratories?
In 2023, Quntrol Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Azpire Pharma Private LimitedActive 5 years 5 months
Riddhi Javeri and Sahil Javeri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quntrol Laboratories?
Unlock and access historical data on people associated with Quntrol Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quntrol Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quntrol Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
